Small Cell Lung Cancer (SCLC) Latest Advances

Find the Latest Research About Small Cell Lung Cancer (SCLC)

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13753 publications

Bi-level Multi-criteria Optimization for Risk-informed Radiotherapy.

Bi-level Multi-criteria Optimization for Risk-informed Radiotherapy.

Journal: Physics in medicine and biology
Published: June 23, 2026

Corrigendum to "POU2F3 in Small Cell Lung Cancer (SCLC): Diagnostic Utility in Neuroendocrine-Low/Negative SCLC and Discrimination From Other Thoracic Malignancies and Other Small Blue Round Cell Tumors" [Laboratory Investigation 2026;106(6):106124].

Corrigendum to "POU2F3 in Small Cell Lung Cancer (SCLC): Diagnostic Utility in Neuroendocrine-Low/Negative SCLC and Discrimination From Other Thoracic Malignancies and Other Small Blue Round Cell Tumors" [Laboratory Investigation 2026;106(6):106124].

Journal: Laboratory investigation; a journal of technical methods and pathology
Published: June 18, 2026

FDA Announces Efforts to Implement Real-Time Clinical Trial Reporting.

FDA Announces Efforts to Implement Real-Time Clinical Trial Reporting.

Journal: Cancer discovery
Published: June 17, 2026

Correction: Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer.

Correction: Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer.

Journal: Scientific reports
Published: June 16, 2026

Time-dependent prognostic impact of distant metastatic sites in small cell lung cancer: a comparative analysis of pre- and post-immunotherapy eras.

Time-dependent prognostic impact of distant metastatic sites in small cell lung cancer: a comparative analysis of pre- and post-immunotherapy eras.

Journal: Immunotherapy
Published: June 15, 2026

A Case of EGFR-mutant Lung Adenocarcinoma with Secondary SCLC Transformation and ALK Fusion after Osimertinib Treatment

A Case of EGFR-mutant Lung Adenocarcinoma with Secondary SCLC Transformation and ALK Fusion after Osimertinib Treatment

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: June 15, 2026

Paraneoplastic neurologic syndrome in a 65-year-old woman with small cell lung cancer.

Paraneoplastic neurologic syndrome in a 65-year-old woman with small cell lung cancer.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: June 15, 2026

Chinese Expert Consensus on Delta-like Ligand 3-T Cell Engager Therapy 
for SCLC

Chinese Expert Consensus on Delta-like Ligand 3-T Cell Engager Therapy 
for SCLC

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: June 15, 2026

A case of anti-Kelch-like protein 11 (KLHL11) antibody-positive opsoclonus-myoclonus syndrome associated with small cell lung cancer that improved after immunotherapy and cancer treatment

A case of anti-Kelch-like protein 11 (KLHL11) antibody-positive opsoclonus-myoclonus syndrome associated with small cell lung cancer that improved after immunotherapy and cancer treatment

Journal: Rinsho shinkeigaku = Clinical neurology
Published: June 14, 2026

"Outstanding" ADC Candidates Emerge for SCLC, Other Cancers.

"Outstanding" ADC Candidates Emerge for SCLC, Other Cancers.

Journal: Cancer discovery
Published: June 05, 2026

Effectiveness of carboplatin vs cisplatin in lung cancer chemo-immunotherapy: A systematic review and meta-analysis.

Effectiveness of carboplatin vs cisplatin in lung cancer chemo-immunotherapy: A systematic review and meta-analysis.

Journal: Tumori
Published: June 04, 2026

First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical Trial.

First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology
Published: June 04, 2026
Showing 1-12 of 13,753

Last Updated: 06/30/2026